financetom
Business
financetom
/
Business
/
Oil Majors Notch Legal Victory as Federal Appeals Court Dismisses Case Alleging Collusion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oil Majors Notch Legal Victory as Federal Appeals Court Dismisses Case Alleging Collusion
Sep 16, 2024 12:05 PM

02:44 PM EDT, 09/16/2024 (MT Newswires) -- Exxon Mobil ( XOM ) and Chevron ( CVX ) were among the big oil firms that earned a legal victory when a federal appeals court dismissed a case brought by consumers who alleged that the firms colluded with foreign nations and former President Donald Trump to cut production and raise prices.

The 9th US Circuit Court of Appeals in San Francisco upheld a lower court's decision and said that the court lacked the subject-matter jurisdiction to adjudicate the plaintiffs' allegations of a global oil conspiracy involving the US, Saudi Arabia and Russia.

"Under the political question doctrine, President Trump's decision to negotiate with other countries was a fundamental foreign relations decision," the court said in its opinion. "Subjecting this decision to judicial review would amount to second-guessing the Executive Branch's foreign policy."

In addition, the appeals court held that the plaintiffs failed "sufficiently to allege either direct evidence of an antitrust conspiracy or circumstantial evidence of parallel conduct among competitors and certain 'plus factors' suggesting a conspiracy."

Price: 141.75, Change: +1.14, Percent Change: +0.81

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bristol-Myers Squibb's Multiple Myeloma Treatment Gets European Commission Approval
Bristol-Myers Squibb's Multiple Myeloma Treatment Gets European Commission Approval
Mar 20, 2024
05:44 PM EDT, 03/20/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said late Wednesday the European Commission approved Abecma to treat adult patients with relapsed and refractory multiple myeloma who have received at least two previous therapies. The approval covers patients who have shown disease progression on the last therapy, the company said. Abecma has maintained its orphan designation...
US FCC investigating Amazon over alleged sale of outlawed products
US FCC investigating Amazon over alleged sale of outlawed products
Mar 20, 2024
March 20 (Reuters) - The U.S. Federal Communications Commission is investigating Amazon ( AMZN ) and other retailers for the alleged marketing and selling of unlawful electronic devices, an FCC spokesperson told Reuters on Wednesday. We have several ongoing investigations into retailers, including Amazon ( AMZN ), for potential violations of Commission rules related to the marketing and sale of...
US DOJ to sue Apple for antitrust violations, Bloomberg News reports
US DOJ to sue Apple for antitrust violations, Bloomberg News reports
Mar 20, 2024
March 20 (Reuters) - The U.S. Department of Justice is poised to sue Apple ( AAPL ) as soon as Thursday for allegedly violating antitrust laws by blocking rivals from accessing hardware and software features of its iPhone, Bloomberg News reported on Wednesday. The lawsuit, which is expected to be filed in federal court, escalates the Biden administration's antitrust fights...
GitLab Acquires Oxeye to Enhance Application Security Capabilities
GitLab Acquires Oxeye to Enhance Application Security Capabilities
Mar 20, 2024
05:41 PM EDT, 03/20/2024 (MT Newswires) -- GitLab ( GTLB ) said late Wednesday it has acquired Oxeye, which provides cloud-native application security and risk management services, to accelerate its Static Application Security Testing roadmap. The company said its security capabilities will include enhanced SAST scanning technology to reduce false positives and deliver highly accurate results and actionable insights following...
Copyright 2023-2026 - www.financetom.com All Rights Reserved